Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive

Background: Oncologists often refer to forest plots to determine which patient subgroups may be more likely to benefit from a therapy tested in a randomized clinical trial (RCT). We sought to empirically determine the information content of subgroup comparisons from forest plots of RCTs. Methods: We...

Full description

Bibliographic Details
Main Authors: Andrew W. Hahn, Nazli Dizman, Pavlos Msaouel
Format: Article
Language:English
Published: SAGE Publishing 2022-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221103199